Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
Dosage and Administration: Administer 20ml IV post event
Metformins role has been increasingly acknowledged by different nations, making it the preferred medication for managing type 2 diabetes mellitus (T2DM) in clinical settings ( In addition to treating T2DM, metformin modestly reduces body weight gain, which may be achieved by upregulating growth differentiation factor 15 (GDF15) (Khunti et al., 2021
Angiogenesis (new vessel growth)
Additionally, researchers are investigating combination therapies that incorporate GLP-1 receptor agonists with other pharmacological agents
camaldulensis leaf extract (Lipo-Eucam) shows pharmacologically relevant properties, including antioxidant and anti-aggregation activity and cytotoxic effects against breast cancer cells, suggesting usefulness in addressing oxidative stress and neoplastic conditions ( Eucalyptus as candidates for integrated cancer therapy and redox-based interventions